Stay updated on Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a note that publications shown are automatically filled from PubMed and may not be about the study. Updated the revision tag from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the warning banner about potential data delays due to a lapse in government funding. The banner previously informed users that information on the site may not be up to date and that the agency may not respond until appropriations are enacted.SummaryDifference0.4%

- Check42 days agoChange DetectedMinor UI/layout adjustments and formatting changes on the study details page with no changes to core content like eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.SummaryDifference0.1%

- Check93 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, indicating a minor patch. The removal of 'Back to Top' is a minor UI change and can be disregarded.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.